What Is Testosterone Replacement Therapy?
Testosterone replacement therapy (TRT) involves supplementing the body's natural testosterone production when levels have dropped low enough to cause clinically significant symptoms. It is available in several forms, including injections, transdermal gels or patches, and implantable pellets. Each delivery method has different absorption profiles and maintenance requirements.
It's important to distinguish TRT from casual hormone optimization. The treatment is intended for men diagnosed with hypogonadism — a condition in which the body fails to produce adequate testosterone due to problems with the testes, pituitary gland, or hypothalamus. Simply having testosterone levels at the lower end of the normal range does not automatically indicate a need for treatment. For a deeper look at how testosterone levels shift with age, see how testosterone changes across a man's lifespan.
This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personal medical decisions.
Potential Benefits Supported by Research
For men with confirmed hypogonadism, clinical evidence points to several areas where TRT may produce meaningful improvements.
Improves sexual function in hypogonadal men
Multiple randomized controlled trials have found TRT significantly improves libido and erectile function in men with clinically low testosterone, though it tends to be less effective as a standalone treatment for erectile dysfunction when testosterone levels are in the normal range.
Supports bone mineral density
Testosterone plays a direct role in maintaining bone mass. Studies show TRT can increase bone density in men with hypogonadism, potentially reducing fracture risk — a relevant concern for older adults.
May improve mood and energy levels
Some men with confirmed hypogonadism report reductions in fatigue, irritability, and depressive symptoms with treatment. Effects on mood tend to be more pronounced in those with the lowest baseline levels.
Can help preserve lean muscle mass
Testosterone contributes to muscle protein synthesis. TRT has been shown to support lean body mass in men with deficient levels, which may aid physical function in older adults at risk of sarcopenia (age-related muscle loss).
It is worth noting that many men believe their symptoms are caused by low testosterone when other factors — poor sleep, metabolic conditions, or depression — are equally or more likely culprits. Common misconceptions about low testosterone are widespread and worth understanding before pursuing testing.
Risks and Limitations to Understand
TRT is not without trade-offs. Several risks are well-established, and others remain subjects of ongoing research.
Suppresses the body's natural testosterone production
Exogenous testosterone signals the body to reduce its own production through a feedback loop, which can cause testicular atrophy and impaired sperm production — a significant concern for men who may want to father children.
Raises red blood cell count (polycythemia risk)
TRT commonly increases hematocrit — the proportion of red blood cells in the blood. Elevated hematocrit thickens the blood and can raise the risk of clotting events, requiring regular monitoring.
Cardiovascular safety remains under study
The relationship between TRT and heart health is nuanced. While a large 2023 trial (TRAVERSE) found no increase in major cardiovascular events in men at elevated baseline risk, ongoing monitoring is still recommended, particularly in those with pre-existing heart disease.
Prostate effects require vigilance
TRT is contraindicated in men with active prostate cancer. It can also cause benign prostate tissue to enlarge, potentially worsening lower urinary tract symptoms. PSA levels should be monitored regularly during treatment.
May worsen sleep apnea
Testosterone can exacerbate obstructive sleep apnea, a condition already more prevalent in older and overweight men. Undiagnosed sleep apnea should be screened for prior to starting TRT.
~2%
Annual testosterone decline after age 30
Research generally estimates testosterone levels fall by roughly 1–2% per year in men after their early 30s, though individual variation is substantial.
~2–4%
Men with clinical hypogonadism in older age groups
Population studies suggest clinically significant hypogonadism affects an estimated 2–4% of middle-aged and older men, though symptom-based prevalence estimates vary more widely.
Men with a history of prostate cancer, significant cardiovascular disease, untreated sleep apnea, or elevated red blood cell counts require particular caution. See the broader context of prostate health treatment decisions for related considerations. For the evolving cardiovascular picture, hormones and heart health across different decades provides useful background.
What the Evaluation Process Involves
A responsible workup before starting TRT generally includes at least two morning blood tests confirming low total testosterone levels, a review of symptoms, and an assessment of overall health — including prostate-specific antigen (PSA) screening and cardiovascular risk factors. A single low reading is not sufficient for diagnosis, as testosterone levels vary naturally throughout the day and across weeks.
Why Two Tests Matter
Because testosterone secretion follows a circadian rhythm — peaking in the morning — clinical guidelines recommend drawing blood samples in the morning and confirming low levels on at least two separate occasions before making a diagnosis. A single borderline result, particularly taken later in the day, can be misleading. Symptoms alone are not sufficient to diagnose hypogonadism, as many overlap with other treatable conditions.
Men who are found not to meet the threshold for TRT, or who prefer to avoid it, may benefit from exploring evidence-based lifestyle practices. Lifestyle habits that support hormonal balance — including exercise, sleep quality, and weight management — can have a meaningful effect on testosterone levels over time.
